New device hopes to help kidneys in liver patients
NCT ID NCT04898010
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called the Selective Cytopheretic Device (SCD) in ICU patients with acute kidney injury and hepatorenal syndrome, a serious complication of liver disease. The device filters white blood cells from the blood for 7 days to see if it improves kidney function and blood circulation. The study involves 10 participants who are not on a liver transplant list and have worsening kidney failure. The main goals are to check safety and whether the device helps patients become dialysis-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States